비경구 영양 - 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 : 영양제 유형별, 최종 사용자별 시장 규모 및 예측, 시장 점유율, 성장 기회 분석

Parenteral Nutrition Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis By Nutrient Type and End User

US $ 4,450 ￦ 6,602,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 6,450 ￦ 9,569,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450 ￦ 12,537,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

비경구 영양 시장 규모는 2022년 68억 4,000만 달러로 평가되었습니다. 2030년에는 112억 1,000만 달러에 달할 것으로 예상되며, 2022-2030년간 연평균 6.2%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 추정됩니다.

비경구 영양은 수분, 비타민, 미네랄, 미량 원소, 아미노산, 전해질 등을 정맥으로 투여하는 영양 보충의 일종입니다. 경장(위 또는 장) 영양에 비해 비경구 영양은 더 복잡하고 비용이 많이 들고 감염 위험이 높으며 입원 기간이 길어집니다. 비경구 영양은 경장 영양을 섭취할 수 없는 환자에게만 처방됩니다. 비경구 영양 요법의 목표는 영양 상태 회복, 저단백혈증 치료, 근력 약화 회복, 기타 영양 결핍을 보충하는 것입니다.

비경구 영양요법 시장 동향에는 영양 제품 처방의 기술 혁신이 포함됩니다. 소비자의 적극적인 건강 관리를 돕는 제품, 특히 에너지 수준, 면역력, 질병 치료와 같은 특정 요구에 초점을 맞춘 제품에 대한 수요가 급증하고 있습니다. 질병의 유형에 따라 필요한 영양은 다릅니다. 비경구 제품의 기능성과 특정 처방은 환자에게 제공되는 기존 치료를 방해하지 않고 필요한 조건에 따라 보다 정확하고 강화된 치료를 제공하는 데 도움이 됩니다. 비경구 영양의 다량 영양소 및 미량 영양소 제제와 그 용도는 암, 소화기 질환과 같은 질병 유형에 따라 다릅니다.

혁신적인 제형의 눈부신 발전으로 환자 개개인의 병적 상태뿐만 아니라 모든 개인의 요구 사항을 충족하도록 설계된 영양 솔루션의 새로운 시대가 도래했습니다. 이러한 수준의 개별화는 비경구 영양의 효과를 향상시킬 뿐만 아니라 환자의 결과를 개선할 수 있습니다. 제형 혁신을 통해 시장은 신생아부터 노인, 특정 질환을 가진 환자까지 다양한 환자의 고유 한 영양 요구를 완벽하게 충족시킬 수 있습니다. 예를 들어, 안정성과 생체 이용률이 개선된 지질 기반 에멀젼의 출현은 특히 미숙아 치료에서 정맥 영양의 양상을 바꾸고 있습니다. 또한, 이러한 제형 혁신으로 인해 기존 영양제의 문제점과 부작용의 위험도 감소하고 있습니다. 이 산업은 헬스케어 생태계에서 비경구 영양의 채택을 촉진하고 환자 치료를 개선하는 두 가지 이점을 통해 탁월한 성장과 장기적인 성공을 거둘 수 있을 것으로 기대됩니다.

영양 유형별, 비경구 영양 시장 기반 인사이트

비경구 영양 시장은 영양 유형별로 1회용 아미노산 용액, 비경구 지질 에멀젼, 탄수화물, 미량 원소, 비타민 및 미네랄로 분류되며, 2022년에는 1회용 아미노산 용액 부문이 비경구 영양 시장 점유율을 장악하고 비경구 지질 에멀젼 부문이 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 가장 높은 CAGR을 기록할 가능성이 높습니다. 중증 환자의 단백질 이화 작용을 늦추기 위해 다량의 단백질을 공급하지만 유해한 에너지를 공급하지 않는 비경구 아미노산과 같은 영양 요법에 대한 요구가 증가하고 있습니다.

비경구 영양제 시장 : 최종 사용자별 인사이트

최종 사용자별로 비경구 영양 시장은 병원, 클리닉 및 기타로 분류됩니다. 병원 부문은 2022년 시장에서 가장 큰 점유율을 차지했지만, 클리닉 부문은 2022-2030년 비경구 영양 시장에서 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 병원은 사용 가능한 모든 시설을 갖춘 가장 큰 사업체로 간주됩니다. 병원은 또한 보험 청구로 환급받을 수 있는 다양한 진단 및 치료 시설을 제공합니다. 병원은 다양한 의사, 전문의 및 향상된 의료 서비스를 제공하는 기타 전문가와 관련이 있습니다. 모든 유형의 순환기 질환은 병원에서 치료할 수 있습니다. 병원은 다양한 질병으로 고통받는 환자에게 간호 서비스를 포함한 광범위한 의료 서비스를 제공함으로써 중요한 역할을 수행합니다. 이 때문에 병원 내 환자들 사이에서 일부 질병과 수술에 대한 경피 약물 전달 시스템의 채택이 증가했습니다.

제약 및 의료 규제 기관, Element-Nutrition-Deck, 국가 통계청, National Institute for Clinical Excellence 등은 비경구 영양 시장에 대한 보고서를 작성할 때 참고한 주요 보조 정보 중 일부입니다.

목차

제1장 서론

제2장 주요 요약

• 주요 인사이트
• 비경구 영양 시장 : 지역별

제3장 조사 방법

• 조사 범위
• 2차 조사
• 1차 조사

제4장 비경구 영양 시장 구도

• 세계의 PEST 분석

제5장 비경구 영양 시장 - 주요 산업 역학

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 동향
• 영향 분석

제6장 비경구 영양 시장 : 세계 시장 분석

• 비경구 영양 시장 매출, 2022년-2030년

제7장 비경구 영양 시장 분석 : 영양제 유형별

• 단회투여 아미노산 용액
• 비경구 지질 에멀전
• 탄수화물
• 미량 원소
• 비타민 및 미네랄

제8장 비경구 영양 시장 분석 : 최종사용자별

• 병원
• 진료소
• 기타

제9장 비경구 영양 시장 : 지역별 분석

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • APAC 기타 국가
• 중동 및 아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국
  • 기타 중동 및 아프리카
• 중남미
  • 중남미
    • 브라질
    • 아르헨티나
    • 기타 중남미

제10장 업계 상황

제11장 기업 개요

• ICU Medical Inc
• Grifols SA
• Pfizer Inc
• Otsuka Pharmaceuticals Co Ltd
• Baxter International Inc
• B Braun SE
• Fresenius Kabi AG
• Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
• Vifor Pharma Management AG
• Aculife Healthcare Pvt Ltd

제12장 부록

LSH

영문 목차

영문목차

The parenteral nutrition market size was valued at US$ 6.84 billion in 2022 and is expected to reach US$ 11.21 billion by 2030. The market is estimated to register a CAGR of 6.2% from 2022 to 2030.

Parenteral nutrition is a type of nutritional supplementation administered intravenously that includes fluids, vitamins, minerals, trace elements, amino acids, and electrolytes. Compared to enteral (gastric or intestinal) feeding, parenteral nutrition is more complex, more costly, and linked to a higher risk of infection and longer hospital stays. Only patients who are unable to receive nutrition enterally are prescribed parenteral nutrition. The goals of parenteral nutrition therapy include restoring nutritional status, treating hypoproteinemia, fixing muscle weakness, and replacing other nutritional deficits.

The parenteral nutrition market trends include innovation in formulations of nutrition products. There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.

Significant developments in innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care.

.

By Nutrient Type, Parenteral Nutrition Market-Based Insights

The parenteral nutrition market, by nutrient type, is segmented into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals. In 2022, the single dose amino acid solution segment dominated the parenteral nutrition market share; and the parenteral lipid emulsion segment is likely to register the highest CAGR during the forecast period. There is a growing need for nutrition therapies such as parenteral amino acids that deliver a substantial amount of protein, but not a toxic amount of energy, to slow down protein catabolism in critically ill patients.

By End User, Parenteral Nutrition Market -Based Insights

In terms of end user, the parenteral nutrition market is categorized into hospitals, clinics, and others. The hospitals segment held the largest share of the market in 2022; however, the clinic segment is anticipated to register the highest CAGR in the parenteral nutrition market during 2022-2030. Hospitals are considered the largest entities that have all the facilities available. Hospitals also provide various diagnostics and treatment facilities that can be reimbursed under insurance claims. Hospitals are associated with various doctors, specialists' doctors, and other professionals who provide enhanced healthcare services. All types of cardiovascular diseases can be treated in hospitals. Hospitals serve a substantial role by providing extensive medical services, including nursing services, to patients suffering from a variety of diseases. This increased the adoption of transdermal drug delivery systems for several diseases and surgeries among patients in hospitals.

Medicines and Healthcare Regulatory Authority, Element-Nutrition-Deck, Office for National Statistics, and National Institute for Clinical Excellence are a few of the major secondary sources referred to while preparing the report on the parenteral nutrition market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Parenteral Nutrition Market, by Geography (US$ Million)

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Parenteral Nutrition Market Landscape

• 4.1 Overview
• 4.2 Global PEST Analysis

5. Parenteral Nutrition Market - Key Industry Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
  • 5.1.2 Surge in Cases of Malnutrition and Premature Births
• 5.2 Market Restraints
  • 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
• 5.3 Market Opportunities
  • 5.3.1 New Product Developments by Companies
• 5.4 Future Trends
  • 5.4.1 Innovation in Formulations of Nutrition Products
• 5.5 Impact Analysis

6. Parenteral Nutrition Market - Global Market Analysis

• 6.1 Parenteral Nutrition Market Revenue (US$ Mn), 2022 - 2030

7. Parenteral Nutrition Market Analysis - by Nutrient Type

• 7.1 Overview
• 7.2 Single Dose Amino Acid Solution
  • 7.2.1 Overview
  • 7.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
• 7.3 Parenteral Lipid Emulsion
  • 7.3.1 Overview
  • 7.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Carbohydrates
  • 7.4.1 Overview
  • 7.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Trace Elements
  • 7.5.1 Overview
  • 7.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Vitamins and Minerals
  • 7.6.1 Overview
  • 7.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Parenteral Nutrition Market Analysis - by End User

• 8.1 Overview
• 8.2 Hospitals
  • 8.2.1 Overview
  • 8.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
• 8.3 Clinics
  • 8.3.1 Overview
  • 8.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Others
  • 8.4.1 Overview
  • 8.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

9. Parenteral Nutrition Market - Geographical Analysis

• 9.1 North America: Parenteral Nutrition Market
  • 9.1.1 Overview
  • 9.1.2 North America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.1.2.1 North America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Nutrient Type
    • 9.1.2.2 North America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by End User
  • 9.1.3 North America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
    • 9.1.3.1 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.3.1.1 Overview
      • 9.1.3.1.2 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.3.1.3 United States: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.1.3.1.4 United States: Parenteral Nutrition Market Breakdown, by End User
    • 9.1.3.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.3.2.1 Overview
      • 9.1.3.2.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.3.2.3 Canada: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.1.3.2.4 Canada: Parenteral Nutrition Market Breakdown, by End User
    • 9.1.3.3 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.3.3.1 Overview
      • 9.1.3.3.2 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.3.3.3 Mexico: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.1.3.3.4 Mexico: Parenteral Nutrition Market Breakdown, by End User
• 9.2 Europe
  • 9.2.1 Overview
  • 9.2.2 Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.2.2.1 Europe: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Nutrient Type
    • 9.2.2.2 Europe: Parenteral Nutrition Market - Revenue and Forecast Analysis - by End User
  • 9.2.3 Europe: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
    • 9.2.3.1 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.1.1 Overview
      • 9.2.3.1.2 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.1.3 Germany: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.2.3.1.4 Germany: Parenteral Nutrition Market Breakdown, by End User
    • 9.2.3.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.2.1 Overview
      • 9.2.3.2.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.2.3 United Kingdom: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.2.3.2.4 United Kingdom: Parenteral Nutrition Market Breakdown, by End User
    • 9.2.3.3 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.3.1 Overview
      • 9.2.3.3.2 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.3.3 France: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.2.3.3.4 France: Parenteral Nutrition Market Breakdown, by End User
    • 9.2.3.4 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.4.1 Overview
      • 9.2.3.4.2 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.4.3 Italy: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.2.3.4.4 Italy: Parenteral Nutrition Market Breakdown, by End User
    • 9.2.3.5 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.5.1 Overview
      • 9.2.3.5.2 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.5.3 Spain: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.2.3.5.4 Spain: Parenteral Nutrition Market Breakdown, by End User
    • 9.2.3.6 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.6.1 Overview
      • 9.2.3.6.2 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.2.3.6.3 Rest of Europe: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.2.3.6.4 Rest of Europe: Parenteral Nutrition Market Breakdown, by End User
• 9.3 Asia Pacific
  • 9.3.1 Overview
  • 9.3.2 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.2.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Nutrient Type
    • 9.3.2.2 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by End User
  • 9.3.3 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
    • 9.3.3.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.1.1 Overview
      • 9.3.3.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.3.3.1.4 China: Parenteral Nutrition Market Breakdown, by End User
    • 9.3.3.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.2.1 Overview
      • 9.3.3.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.3.3.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
    • 9.3.3.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.3.1 Overview
      • 9.3.3.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.3.3.3.4 India: Parenteral Nutrition Market Breakdown, by End User
    • 9.3.3.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.4.1 Overview
      • 9.3.3.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.3.3.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
    • 9.3.3.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.5.1 Overview
      • 9.3.3.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.3.3.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
    • 9.3.3.6 Rest of APAC: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.6.1 Overview
      • 9.3.3.6.2 Rest of APAC: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.3.6.3 Rest of APAC: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.3.3.6.4 Rest of APAC: Parenteral Nutrition Market Breakdown, by End User
• 9.4 Middle East and Africa
  • 9.4.1 Overview
  • 9.4.2 Middle East and Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.4.2.1 Middle East and Africa: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Nutrient Type
    • 9.4.2.2 Middle East and Africa: Parenteral Nutrition Market - Revenue and Forecast Analysis - by End User
  • 9.4.3 Middle East and Africa: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
    • 9.4.3.1 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.1.1 Overview
      • 9.4.3.1.2 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.1.3 Saudi Arabia: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.4.3.1.4 Saudi Arabia: Parenteral Nutrition Market Breakdown, by End User
    • 9.4.3.2 United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.2.1 Overview
      • 9.4.3.2.2 United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.2.3 United Arab Emirates: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.4.3.2.4 United Arab Emirates: Parenteral Nutrition Market Breakdown, by End User
    • 9.4.3.3 South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.3.1 Overview
      • 9.4.3.3.2 South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.3.3 South Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.4.3.3.4 South Africa: Parenteral Nutrition Market Breakdown, by End User
    • 9.4.3.4 Rest of Middle East and Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.4.1 Overview
      • 9.4.3.4.2 Rest of Middle East and Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.3.4.3 Rest of Middle East and Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.4.3.4.4 Rest of Middle East and Africa: Parenteral Nutrition Market Breakdown, by End User
• 9.5 South and Central America
  • 9.5.1 Overview
  • 9.5.2 The South & Central South and Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.5.2.1 South and Central America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Nutrient Type
    • 9.5.2.2 South and Central America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by End User
  • 9.5.3 South and Central America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
    • 9.5.3.1 Brazil: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.5.3.1.1 Overview
      • 9.5.3.1.2 Brazil: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.5.3.1.3 Brazil: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.5.3.1.4 Brazil: Parenteral Nutrition Market Breakdown, by End User
    • 9.5.3.2 Argentina: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.5.3.2.1 Overview
      • 9.5.3.2.2 Argentina: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.5.3.2.3 Argentina: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.5.3.2.4 Argentina: Parenteral Nutrition Market Breakdown, by End User
    • 9.5.3.3 Rest of South and Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.5.3.3.1 Overview
      • 9.5.3.3.2 Rest of South and Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.5.3.3.3 Rest of South and Central America: Parenteral Nutrition Market Breakdown, by Nutrient Type
      • 9.5.3.3.4 Rest of South and Central America: Parenteral Nutrition Market Breakdown, by End User

10. Industry Landscape

• 10.1 Overview
  • 10.1.1 Overview

11. Company Profiles

• 11.1 ICU Medical Inc
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Grifols SA
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Pfizer Inc
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 Otsuka Pharmaceuticals Co Ltd
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Baxter International Inc
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 B Braun SE
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Fresenius Kabi AG
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments
• 11.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
  • 11.8.1 Key Facts
  • 11.8.2 Business Description
  • 11.8.3 Products and Services
  • 11.8.4 Financial Overview
  • 11.8.5 SWOT Analysis
  • 11.8.6 Key Developments
• 11.9 Vifor Pharma Management AG
  • 11.9.1 Key Facts
  • 11.9.2 Business Description
  • 11.9.3 Products and Services
  • 11.9.4 Financial Overview
  • 11.9.5 SWOT Analysis
  • 11.9.6 Key Developments
• 11.10 Aculife Healthcare Pvt Ltd
  • 11.10.1 Key Facts
  • 11.10.2 Business Description
  • 11.10.3 Products and Services
  • 11.10.4 Financial Overview
  • 11.10.5 SWOT Analysis
  • 11.10.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms

관련자료